Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Astellas Pharma Total Liabilities 2012-2024 | ALPMY

Astellas Pharma total liabilities from 2012 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  
Astellas Pharma Annual Total Liabilities
(Millions of US $)
2024 $13,070
2023 $7,132
2022 $7,148
2021 $7,996
2020 $9,440
2019 $5,759
2018 $5,565
2017 $4,903
2016 $4,483
2015 $4,329
2014 $3,734
2013 $4,080
2012 $4,665
2011 $0
2010 $0
2009 $0
Astellas Pharma Quarterly Total Liabilities
(Millions of US $)
2024-06-30 $13,178
2023-06-30 $8,903
2022-06-30 $7,259
2021-06-30 $7,886
2020-06-30 $8,829
2019-06-30 $6,164
2018-06-30 $5,434
2017-06-30 $5,234
2016-09-30 $4,762
2016-06-30 $4,679
2016-03-31 $4,483
2015-12-31 $3,817
2015-09-30 $3,670
2015-06-30 $3,659
2015-03-31 $4,329
2014-12-31 $4,203
2014-09-30 $4,034
2014-06-30 $3,787
2014-03-31 $3,734
2013-12-31 $4,048
2013-09-30 $3,782
2013-06-30 $3,856
2013-03-31 $4,080
2012-12-31 $4,512
2012-09-30 $4,016
2012-06-30 $4,401
2012-03-31 $4,665
2011-12-31 $4,711
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $12.558B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $88.594B 33.24
Zoetis (ZTS) United States $72.088B 26.90
Daiichi Sankyo, - (DSNKY) Japan $45.227B 23.01
Takeda Pharmaceutical (TAK) Japan $45.151B 8.98
Sandoz Group AG (SDZNY) Switzerland $19.811B 0.00
Summit Therapeutics (SMMT) United States $18.760B 0.00
Merck (MKKGY) Germany $18.016B 14.91
United Therapeutics (UTHR) United States $14.019B 12.40
Shionogi (SGIOY) Japan $13.305B 13.33
Neurocrine Biosciences (NBIX) United States $11.918B 40.82
IPSEN (IPSEY) France $9.397B 0.00
Orion OYJ (ORINY) Finland $8.215B 22.22
Corcept Therapeutics (CORT) United States $7.650B 62.19
Stevanato Group S.p.A (STVN) Italy $7.165B 43.81
Madrigal Pharmaceuticals (MDGL) United States $6.678B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.337B 0.00
Grifols, S.A (GRFS) Spain $5.315B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Soleno Therapeutics (SLNO) United States $3.865B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.120B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.907B 10.18
Hypermarcas (HYPMY) Brazil $2.591B 17.04
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.356B 12.88
BioCryst Pharmaceuticals (BCRX) United States $2.164B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.111B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.886B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.757B 0.00
Guardian Pharmacy Services (GRDN) United States $1.624B 0.00
Indivior (INDV) United States $1.564B 6.63
Evotec AG (EVO) Germany $1.481B 0.00
Dyne Therapeutics (DYN) United States $1.428B 0.00
ARS Pharmaceuticals (SPRY) United States $1.305B 166.12
Ocular Therapeutix (OCUL) United States $1.177B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.110B 21.95
Harrow (HROW) United States $0.978B 0.00
Collegium Pharmaceutical (COLL) United States $0.950B 5.12
Enliven Therapeutics (ELVN) United States $0.933B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.927B 0.00
Ardelyx (ARDX) United States $0.845B 0.00
Cronos Group (CRON) Canada $0.790B 0.00
Xeris Biopharma Holdings (XERS) United States $0.774B 0.00
AleAnna (ANNA) United States $0.712B 0.00
Akebia Therapeutics (AKBA) United States $0.638B 0.00
Xencor (XNCR) United States $0.624B 0.00
KalVista Pharmaceuticals (KALV) United States $0.606B 0.00
USANA Health Sciences (USNA) United States $0.559B 12.15
Bioventus (BVS) United States $0.552B 14.04
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Relay Therapeutics (RLAY) United States $0.533B 0.00
Savara (SVRA) United States $0.522B 0.00
CytoDyn (CYDY) United States $0.476B 0.00
Elite Pharmaceuticals (ELTP) United States $0.465B 0.00
Altimmune (ALT) United States $0.463B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.440B 0.00
Siga Technologies (SIGA) United States $0.424B 8.87
Zevra Therapeutics (ZVRA) United States $0.424B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.410B 0.00
Tourmaline Bio (TRML) United States $0.405B 0.00
Verve Therapeutics (VERV) United States $0.388B 0.00
Organogenesis (ORGO) United States $0.379B 0.00
Oruka Therapeutics (ORKA) United States $0.365B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.333B 8.99
Heron Therapeutics (HRTX) United States $0.313B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.265B 24.48
ProKidney (PROK) United States $0.220B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Avita Medical (RCEL) United States $0.192B 0.00
Liminatus Pharma (LIMN) $0.185B 0.00
Wellgistics Health (WGRX) United States $0.184B 0.00
OmniAb (OABI) United States $0.175B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Inhibikase Therapeutics (IKT) United States $0.163B 0.00
Esperion Therapeutics (ESPR) United States $0.158B 0.00
Journey Medical (DERM) United States $0.158B 0.00
Nanobiotix S.A (NBTX) France $0.157B 0.00
4D Molecular Therapeutics (FDMT) United States $0.154B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Aclaris Therapeutics (ACRS) United States $0.135B 0.00
Larimar Therapeutics (LRMR) United States $0.133B 0.00
Nektar Therapeutics (NKTR) United States $0.133B 0.00
Aldeyra Therapeutics (ALDX) United States $0.132B 0.00
Profound Medical (PROF) Canada $0.129B 0.00
Protara Therapeutics (TARA) United States $0.126B 0.00
Lyell Immunopharma (LYEL) United States $0.125B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.123B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.119B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.118B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.092B 0.00
Cassava Sciences (SAVA) United States $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Lexeo Therapeutics (LXEO) United States $0.087B 0.00
Achieve Life Sciences (ACHV) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
Fractyl Health (GUTS) United States $0.084B 0.00
Champions Oncology (CSBR) United States $0.083B 13.64
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 58.56
Inotiv (NOTV) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Context Therapeutics (CNTX) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.068B 0.00
Nutriband (NTRB) United States $0.065B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Karyopharm Therapeutics (KPTI) United States $0.053B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.043B 0.00
Prelude Therapeutics (PRLD) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Mannatech (MTEX) United States $0.023B 9.00
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
DURECT (DRRX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.58
Plus Therapeutics (PSTV) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00